500 patients to be tracked in Long-Term scleroderma study

NCT ID NCT04265144

First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 21 times

Summary

This study follows 500 adults with systemic sclerosis (a rare autoimmune disease causing skin thickening and organ damage) over 5 years. Researchers will track how the disease naturally progresses by monitoring key complications like lung and kidney problems. They will also collect blood samples to better understand the disease and support future research.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU de Bordeaux - service de rhumatologie

    RECRUITING

    Bordeaux, France

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.